A point prevalence survey on levels of healthcare-associated infections (HAI) and levels of antimicrobial use in hospitals in England in 2016.
Over 4 million people in Europe get a healthcare-associated infection (HAI) every year, and around 37,000 die as a direct result of the infection. Antimicrobial use (AMU) is a key driver of antimicrobial resistance (AMR); understanding the indications, dose used, and adherence to guidelines is important to reduce antibiotic consumption.
Surveillance of HAI and AMU is an essential part of infection prevention and antimicrobial stewardship. It drives action by planning and implementing more effective, evidence based policies, surveillance and strategies.
The objectives of the point prevalence survey of HAIs and AMU in acute-care hospitals are to:
- estimate the total burden (prevalence) of HAIs and AMU in acute-care hospitals;
- describe patients, invasive procedures, infections (sites, microorganisms including markers of antimicrobial resistance) and antimicrobials prescribed (compounds, indications)
- describe key structures and processes for the prevention of HAIs and antimicrobial resistance at the hospital and ward level in EU hospitals
- disseminate results to those who need to know at local, regional and national levels